Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Share Price and Perception Issues
View:
Post by givmeabrake on Oct 07, 2015 10:11pm

Share Price and Perception Issues

Compare Top 10 Cad biotech stocks, prices, average under $2.00.

https://www.cantechletter.com/2012/07/canadas-10-hottest-biotech-stocks/




With

List of Nasdaq biotechs

99% over $4.00. Most WELL over $15.00

https://ca.finance.yahoo.com/q/cp?s=%5ENBI


A $4.00 Telesta stock on Nasdaq is perfectly reasonable. Exposure to HUGE investor pool.

HUGE!!!!

WHO btw will DEMAND and EXPECT increases to shareholder value. Something you and I have failed to do...

Face it kids, we're cheap and too polite.... doesn't pan out in the end. I think we NEED NASDAQ. Not just to open door. To light a fire under management when it comes to promo and communications.
Comment by somweyungguy on Oct 07, 2015 11:36pm
More strategy than issue chum...you know that, you deliver it
Comment by DryBones on Oct 07, 2015 11:58pm
You prove nothing with a 3 year old list other than that Cantech can't pick biotech stocks.  Only one out of 10 managed a slight rise. In the US. there are approximately 1000 microcap biotech stocks.  So some made it to the Naz, who cares.  The failure rate is bound to be high there too.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities